EMIS Insights | Poland Pharma & Healthcare Sector Report 2022-2023
What does this sample report offer?
Despite an initially effective response to the outbreak of the pandemic, some say that Poland lost the war against COVID-19 and the virus has exposed years of neglect. As a result of the pandemic, the life expectancy of Poles has decreased and, in this respect, Poland has one of the worst outcomes in Europe as well as in terms of excess deaths.
This report provides a comprehensive sector overview, with this sample providing access to:
- Entry modes and segment oppportunities
- Demographic and health profile
- Regional positioning and production
- Healthcare sales and expenditure
- FDI in pharmaceutical manufacturing value
About EMIS Insights
EMIS operates in and reports on countries where high reward goes hand-in-hand with high risk. We bring you time-sensitive, hard-to-get, relevant news, research and analytical data, peer comparisons and more for over 197 emerging markets. Our EMIS Insights Report suite constitutes just a proportion of our deep emerging markets information platform, which you can learn more about
here. Alternatively, explore our pay-as-you-go offerings with our EMIS Insights Industry Reports
here.